Product: Hemo One
Subject: External Evaluation results for Hemo One platform for HbA1c.
(Informative note: INCC02/2016)
Dear Valued Customer,
Thank you for choosing Adaltis S.r.l.
Please, note that this bulletin contains important information for your Marketing and Sales department.
We are proud to inform you that we have received the results of the “PROGRAMMA di VALUTAZIONE ESTERNA di QUALITA' 2015”
managed by “Azienda Ospedaliera Università di Padova – Centro di Ricerca Biomedica” - http://www.centroricercabiomedica.net/.
ISE S.r.l Laboratory (Sister company of Adaltis S.r.l.) have participate and tested the blind samples, provided in 4 different exercises
during the year 2015, with the Hemo One instrument and dedicated reagents for the detection of HbA1C (IFCC).
The conclusion of the study is that the 100% of the results achieved by the Hemo One system, have been classified as correctly
reported. Enclosed you will find the Certificate released by the Centro di Ricerca Biomedica.
For more product information about the HEMO One system.
If you have any question please, contact our Sales Department via email at email@example.com.
We will be pleased to be at your service.